Walkner Condon Financial Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$375K Sell
1,035
-4
-0.4% -$1.37K 0.04% 231
2026
Q1
$366K Buy
1,039
+75
+8% +$26.7K 0.05% 213
2025
Q4
$316K Buy
964
+58
+6% +$18.4K 0.04% 235
2025
Q3
$256K Sell
906
-27
-3% -$7.83K 0.04% 250
2025
Q2
$261K Buy
933
+72
+8% +$20.4K 0.05% 235
2025
Q1
$268K Buy
+861
New +$254K 0.05% 221
2024
Q4
Sell
-1,680
Closed -$541K 284
2024
Q3
$541K Buy
1,680
+404
+32% +$132K 0.11% 148
2024
Q2
$399K Sell
1,276
-165
-11% -$48.5K 0.09% 165
2024
Q1
$410K Sell
1,441
-12
-0.8% -$3.51K 0.09% 175
2023
Q4
$418K Buy
1,453
+123
+9% +$33.5K 0.1% 172
2023
Q3
$357K Buy
1,330
+395
+42% +$98.6K 0.09% 164
2023
Q2
$208K Sell
935
-103
-10% -$23.9K 0.05% 228
2023
Q1
$251K Buy
1,038
+17
+2% +$4.17K 0.07% 197
2022
Q4
$268K Sell
1,021
-42
-4% -$11.3K 0.08% 183
2022
Q3
$240K Buy
1,063
+74
+7% +$17.9K 0.08% 186
2022
Q2
$241K Buy
989
+78
+9% +$19.1K 0.08% 194
2022
Q1
$220K Buy
+911
New +$209K 0.06% 202

Other funds holding AMGN

Walkner Condon Financial Advisors's AMGN Position: Q2 2026 in Review

Walkner Condon Financial Advisors reduced its Amgen (AMGN) stake by 0.38% in Q2 2026, selling an estimated $1.37K and leaving 1,035 shares worth $375K. The position accounts for 0.04% of the portfolio, ranked #231.

Walkner Condon Financial Advisors first reported a position in AMGN in Q1 2022 and has held it in 17 quarters since. The position peaked at $541K in Q3 2024. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Walkner Condon Financial Advisors held 1,035 shares of Amgen worth $375K as of Q2 2026.
  • Walkner Condon Financial Advisors sold 4 Amgen shares in Q2 2026, an estimated $1.37K.
  • Amgen made up 0.04% of Walkner Condon Financial Advisors's portfolio in Q2 2026, its #231 holding.
  • Walkner Condon Financial Advisors first reported a position in Amgen in Q1 2022 and has held it in 17 quarters since.
  • Walkner Condon Financial Advisors's Amgen position peaked at $541K in Q3 2024.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Walkner Condon Financial Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.